发明名称 |
PSEUDOTYPED RETROVIRAL VECTOR FOR GENE THERAPY OF CANCER |
摘要 |
The invention relates to retroviral expression vectors and more particularly to pseudotyped retroviral vectors for gene therapy of cancer. Direct in vivo tumor-targeting with "suicide" viral vectors is limited by inefficient gene transfer and indiscriminate transfer of a contitionally toxic gene to surrounding non-malignant tissue. Retrovectors pseudotyped with a Vesicular Stomatitis Virus G protein (VSVG) may serve as a remedy to this conundrum. These retroviral particles differ from standard murine retroviruses by their very broad tropism and the capacity to be concentrated by ultracentrifugation without loss of activity. A VSVG-typed retrovector can be utilized for efficient and tumor specific Herpes Simplex Virus Thymidine Kinase (TK) gene delivery in vivo. A bicistronic retroviral vector which expresses TK and Green Fluorescence Protein (pTKiGFP) was constructed.
|
申请公布号 |
WO0065034(A2) |
申请公布日期 |
2000.11.02 |
申请号 |
WO2000CA00445 |
申请日期 |
2000.04.20 |
申请人 |
CENTRE FOR TRANSLATIONAL RESEARCH IN CANCER;GALIPEAU, JACQUES |
发明人 |
GALIPEAU, JACQUES |
分类号 |
A61K47/48;A61K48/00;C07K14/145;C12N7/04;C12N15/867;(IPC1-7):C12N15/00 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|